Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 18 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

22%

4 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

N/A
4(33.3%)
Phase 4
3(25.0%)
Early Phase 1
3(25.0%)
Phase 3
1(8.3%)
Phase 2
1(8.3%)
12Total
N/A(4)
Phase 4(3)
Early Phase 1(3)
Phase 3(1)
+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (18)

Showing 18 of 18 trials
NCT07556224Recruiting

Evaluating the Efficacy and Short-Term Prognosis of Integrated Traditional Chinese and Western Medicine for Ankylosing Spondylitis(AS): A Protocol for a Cohort Study

Role: collaborator

NCT07509775Recruiting

Integrated Traditional Chinese and Western Medicine for Ankylosing Spondylitis (AS): A Cohort Study Protocol Focusing on Spondyloarthritis Research Consortium of Canada (SPARCC) Scoring System

Role: collaborator

NCT07032116Not Yet Recruiting

YiqiJiangzhuoHuoxueTongluo Method to Delay the Occurrence of End-stage Renal Disease in Diabetic Kidney Disease--Study1

Role: collaborator

NCT07019714Not ApplicableNot Yet Recruiting

Daoyin Technique for Improving Exercise Endurance in IPF

Role: lead

NCT06455670Not ApplicableNot Yet Recruiting

Effects of Chinese Medicine on Patients With Severe Acute Exacerbation of COPD

Role: collaborator

NCT04897126Phase 4Completed

Efficacy and Safety of Shexiang Baoxin Pill in Patients With Ischemia With Non-Obstructive Coronary Artery

Role: collaborator

NCT06373692Not Yet Recruiting

REspiratory diSEAse cohoRt Studies of CHinese Medicine for Asthma (RESEARCH- Asthma)

Role: collaborator

NCT05369884Early Phase 1Unknown

Efficacy and Safety of WPQW Granule for Overlap of NERD and IBS-D

Role: collaborator

NCT02955134Not ApplicableCompleted

The Study of Chinese Medicine for the Treatment of Chronic Atrophic Gastritis

Role: collaborator

NCT04202588Unknown

A Cross-sectional Investigation on Characteristics of Gastrointestinal Symptoms in China

Role: collaborator

NCT04875299Unknown

Optimal Adalimumab Plasma Concentrations in Ankylosing Spondylitis Patients

Role: collaborator

NCT04150835Phase 4Unknown

Xingnaojing for Mild-to-severe Acute Ischemic Stroke

Role: collaborator

NCT04711980Early Phase 1Unknown

Post-marketing Evaluation of Mudan Granule Intervention on Type 2 Diabetic Peripheral Neuropathy

Role: collaborator

NCT04208581Phase 3Unknown

Yiqi Huoxue Huatan Granule for Reducing Mortality in COPD With Chronic Respiratory Failure

Role: collaborator

NCT04078711Phase 2Unknown

Chinese Medicine Treat for Hypertensive Renal Injury

Role: collaborator

NCT03947411Not ApplicableUnknown

Evaluate the Safety and Efficacy of Xiyanping in Pediatric Participants With Severe Influenza-Like Symptoms

Role: collaborator

NCT03010241Early Phase 1Unknown

The Multi-Centric Clinical Study of Chinese Medicine Intervention on Diabetes Distal Symmetric Polyneuropathy.

Role: collaborator

NCT00548223Phase 4Completed

The Secondary Prevention Trial for Ischemic Stroke With DengzhanShengmai Capsule

Role: collaborator

All 18 trials loaded